Inventor · disambiguated record
Dirk Jager
Also filed as: JAEGER DIRK · JAGER DIRK · JÄGER Dirk · OLD LLOYD
16 granted patents·7 pending applications·157 citations·filing 1999–2023
91Inventor score
Files withLUDWIG INST CANCER RES8UNIV HEIDELBERG RUPRECHT KARLS3DEUTSCHES KREBSFORSCH2HEIDELBERG IMMUNOTHERAPEUTICS GMBH2CORNELL RES FOUNDATION INC1
Top patents by PatentIndex Score
23 records- 0197US7314721B2Small cell lung cancer associated antigens and uses thereforLUDWIG INST CANCER RES·Filed 2004·Granted Jan 1, 2008·111 cites·10 claims
- 0284US6911529B1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofSLOAN KETTERING INST CANCER·Filed 2000·Granted Jun 28, 2005·13 cites·13 claims
- 0384US6448073B1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2000·Granted Sep 10, 2002·11 cites·25 claims
- 0473US6774226B1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 1999·Granted Aug 10, 2004·15 cites·18 claims
- 0569US11964015B2Cancer therapy with an oncolytic virus combined with a checkpoint inhibitorDEUTSCHES KREBSFORSCH·Filed 2021·Granted Apr 23, 2024·0 cites·6 claims
- 0667US8071717B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofJAGER DIRK·Filed 2009·Granted Dec 6, 2011·0 cites·2 claims
- 0766US11027013B2Cancer therapy with an oncolytic virus combined with a checkpoint inhibitorDEUTSCHES KREBSFORSCH·Filed 2018·Granted Jun 8, 2021·0 cites·6 claims
- 0866US7795379B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2005·Granted Sep 14, 2010·1 cites·23 claims
- 0966US7622568B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2007·Granted Nov 24, 2009·0 cites·10 claims
- 1064US7795409B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereofLUDWIG INST CANCER RES·Filed 2008·Granted Sep 14, 2010·0 cites·6 claims
- 1164US7354992B2Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofLUDWIG INST CANCER RES·Filed 2003·Granted Apr 8, 2008·0 cites·2 claims
- 1261US7125681B2Methods for detection of disease-associated antibodies in urineLUDWIG INST CANCER RES·Filed 2002·Granted Oct 24, 2006·5 cites·4 claims
- 1361US2022169705A1Topical application for an anti-hsv antibodyHEIDELBERG IMMUNOTHERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1459US7132507B2Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their usesCORNELL RES FOUNDATION INC·Filed 2002·Granted Nov 7, 2006·0 cites·4 claims
- 1558US2024075085A1Cancer therapy involving car-engineered t-cells and parvovirus h-1DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS·Filed 2023·Application pending·0 cites
- 1656US8519106B2Monoclonal human tumor-specific antibodyESSLINGER CHRISTOPH·Filed 2008·Granted Aug 27, 2013·1 cites·14 claims
- 1756US2021000816A1Use of ccr5 antagonists alone or in combination therapy for the treatment of cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2020·Application pending·0 cites
- 1851US11267871B2Topical application for an anti-HSV antibodyHEIDELBERG IMMUNOTHERAPEUTICS GMBH·Filed 2015·Granted Mar 8, 2022·0 cites·19 claims
- 1951US2004126398A1Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereofFiled 2000·Application pending·0 cites
- 2045US2021155660A1Rationally designed virus-like particles for modulation of chimeric antigen receptor (car)-t-cell therapyUNIV HEIDELBERG RUPRECHT KARLS·Filed 2018·Application pending·0 cites
- 2138US11501444B2Method, software module, and integrated circuit for color visualization and separationUNIV HEIDELBERG·Filed 2019·Granted Nov 15, 2022·0 cites·19 claims
- 2238US2012283115A1Seromic analysis of ovarian cancerRITTER GERD·Filed 2010·Application pending·0 cites
- 2334US2018289689A1Use of ccr5 antagonists alone or in combination therapy for the treatment of cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dirk Jager files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →